Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.290
+0.010 (0.78%)
At close: Feb 21, 2025, 4:00 PM
1.260
-0.030 (-2.33%)
After-hours: Feb 21, 2025, 7:45 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.50 million as of February 21, 2025. Its market cap has increased by 11.28% in one year.
Market Cap
5.50M
Enterprise Value
-1.31M
1-Year Change
11.28%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.50M, a decrease of -78.98%. That is a compound annual growth rate of -35.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 5.50M | -1.71% |
| Dec 31, 2024 | 5.60M | 17.66% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |